Zobrazeno 1 - 10
of 318
pro vyhledávání: '"D. Rimoldi"'
Autor:
P, Baumgaertner, C, Costa Nunes, A, Cachot, H, Maby-El Hajjami, L, Cagnon, M, Braun, L, Derré, J-P, Rivals, D, Rimoldi, S, Gnjatic, S, Abed Maillard, P, Marcos Mondéjar, M P, Protti, E, Romano, O, Michielin, P, Romero, D E, Speiser, C, Jandus
Publikováno v:
Oncoimmunology. 5(10)
Long synthetic peptides and CpG-containing oligodeoxynucleotides are promising components for cancer vaccines. In this phase I trial, 19 patients received a mean of 8 (range 1–12) monthly vaccines s.c. composed of the long synthetic NY-ESO-179–10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5bb988e9a30f844a4399887e91824ec
https://pubmed.ncbi.nlm.nih.gov/27853637
https://pubmed.ncbi.nlm.nih.gov/27853637
Autor:
Edoardo Charbon, Krisztian Homicsko, F. Powolny, Elena A. Dubikovskaya, K. Muehlethaler, Jouke Dijkstra, Paulien L. Stegehuis, D. Rimoldi, Harald Homulle, R Sinisi, Du Li, John O. Prior, Claudio Bruschini
Publikováno v:
Biomedical Optics Express, vol. 7, no. 5, pp. 1797-1814
Biomedical Optics Express
Biomedical Optics Express, 7(5), 1797-1814
Biomedical Optics Express
Biomedical Optics Express, 7(5), 1797-1814
In near infrared fluorescence-guided surgical oncology, it is challenging to distinguish healthy from cancerous tissue. One promising research avenue consists in the analysis of the exogenous fluorophores' lifetime, which are however in the (sub-)nan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d78fe1ae044db9c306c259e97988f5f
https://hdl.handle.net/1887/112454
https://hdl.handle.net/1887/112454
Autor:
Juergen Weitz, Friedrich H. Schmitz-Winnenthal, Robert Krempien, Markus W. Büchler, M. Koch, K. Z’graggen, W. Geng, D. Rimoldi, L. V. Galindo-Escobedo, Pedro Romero, Andreas G. Niethammer, Philipp Beckhove
Publikováno v:
Cancer Letters. 252:290-298
Background To be effective and selective, immunotherapy ideally targets specifically tumor cells and spares normal tissues. Identification of tumor specific antigens is a prerequisite to establish an effective immunotherapy. Still very little is know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::925dea9ed2349a3636a7eaa245d8c8c1
https://doi.org/10.1016/j.canlet.2007.01.003
https://doi.org/10.1016/j.canlet.2007.01.003
Publikováno v:
Medicina. 61(5 Pt 1)
The disease caused by Actinomyces spp. is often of difficult diagnosis. Actinomyces spp. are anaerobic or microaerophilic non-spore-forming gram-positive rods that may reach, occasionally, the normal female genital tract. IUD and pessaries facilitate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1b5b40f7a6869c86dc8cd8c8da661f1
https://pubmed.ncbi.nlm.nih.gov/11721325
https://pubmed.ncbi.nlm.nih.gov/11721325
Autor:
V, Dutoit, V, Rubio-Godoy, P Y, Dietrich, A L, Quiqueres, V, Schnuriger, D, Rimoldi, D, Liénard, D, Speiser, P, Guillaume, P, Batard, J C, Cerottini, P, Romero, D, Valmori
Publikováno v:
Cancer research. 61(15)
MAGE-encoded antigens, which are expressed by tumors of many histological types but not in normal tissues, are suitable candidates for vaccine-based immunotherapy of cancers. Thus far, however, T-cell responses to MAGE antigens have been detected onl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5be5afe0c8dadbb6c7da05731a98a610
https://pubmed.ncbi.nlm.nih.gov/11479225
https://pubmed.ncbi.nlm.nih.gov/11479225
Autor:
M J, Pittet, D E, Speiser, D, Liénard, D, Valmori, P, Guillaume, V, Dutoit, D, Rimoldi, F, Lejeune, J C, Cerottini, P, Romero
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7
Peptide-based vaccines are currently being tested for their ability to induce or augment tumor antigen (Ag)-specific CD8+ T-cell responses in cancer patients. Here we report that the frequency of circulating CD8+ T cells directed against the Melan-A/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cda950af7fcf407e92bbc9e01169f7c0
https://pubmed.ncbi.nlm.nih.gov/11300475
https://pubmed.ncbi.nlm.nih.gov/11300475
Autor:
P, Romero, V, Dutoit, V, Rubio-Godoy, D, Liénard, D, Speiser, P, Guillaume, K, Servis, D, Rimoldi, J C, Cerottini, D, Valmori
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 7
We have shown previously that HLA-A*0201 melanoma patients can frequently develop a CTL response to the cancer testis antigen NY-ESO-1. In the present study, we have analyzed in detail the relative antigenicity and in vitro immunogenicity of natural
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bf8af1c05d83e73a30d9279aadbdaaf5
https://pubmed.ncbi.nlm.nih.gov/11300471
https://pubmed.ncbi.nlm.nih.gov/11300471
Publikováno v:
International journal of cancer. 95(1)
In this study we assessed the expression of the Melan-A/MART-1 antigen by immunohistochemistry using monoclonal antibody A103 in 73 primary cutaneous melanomas and its correlation with tumor staging and patient survival. Melan-A/MART-1 was expressed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2abf5ae5bc6b503e84f5e72aabe24c4e
https://pubmed.ncbi.nlm.nih.gov/11241315
https://pubmed.ncbi.nlm.nih.gov/11241315
Autor:
D, Valmori, V, Dutoit, V, Rubio-Godoy, C, Chambaz, D, Liénard, P, Guillaume, P, Romero, J C, Cerottini, D, Rimoldi
Publikováno v:
Cancer research. 61(2)
MAGE genes encode tumor-specific shared antigens that are among the most interesting candidates for cancer vaccines. Despite extensive studies, however, CD8+ T-cell responses to MAGE-derived epitopes have been detected only occasionally in cancer pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::455e14f62953582eb22e89483b5aa4c6
https://pubmed.ncbi.nlm.nih.gov/11212242
https://pubmed.ncbi.nlm.nih.gov/11212242